Stock · Healthcare
Emergent BioSolutions, Inc. EBS
Who in Washington is trading it · Jun 23 – Jan 10
U.S. members of Congress and senior executive-branch officials must disclose their trades in Emergent BioSolutions, Inc. (EBS) under the STOCK Act and federal ethics rules. Below is every disclosed EBS trade we track — who traded it, when it was disclosed, and the disclosed dollar range. Figures are disclosed ranges; disclosure dates lag the trade by 30–45 days.
7Disclosed trades
4Officials
1/2Buys / Sells
$1.0M–$5.1MDisclosed $ volume
7/0Congress / Exec
Who has traded EBS
- Josh Gottheimer (D-NJ) — 4 disclosed trades
- John K. Delaney (D-MD) — 1 disclosed trade
- Kurt Schrader (D-OR) — 1 disclosed trade
- Steve Cohen (D-TN) — 1 disclosed trade
Recent disclosed EBS trades
| Official | Disclosed | Txn | Amount | Flags |
|---|---|---|---|---|
| Steve Cohen | Jan 10 | SELL | $1K–$15K | |
| Josh Gottheimer | Dec 13 | s | $1K–$15K | |
| Josh Gottheimer | Nov 15 | p | $1K–$15K | |
| Josh Gottheimer | Oct 13 | s | $1K–$15K | |
| Josh Gottheimer | Mar 10 | s (partial) | $1K–$15K | |
| Kurt Schrader | Dec 5 | BUY | $1K–$15K | |
| John K. Delaney | Jun 23 | SELL | $1.0M–$5M |